The current year marks a critical turning point as specialized therapies begin to replace the traditional "watch and wait" approach. A comprehensive Adenoid Cystic Carcinoma market trends analysis highlights that the market valuation is being propelled by the emergence of "biomarker-first" strategies. With the global market projected to reach approximately USD 296.87 million by 2030, the focus...